Table 2: Measurements for weight, skinfold-derived fat-free mass, DXA-derived total mass, lean mass (lean soft-tissue mass and bone mass) and lean soft-tissue mass taken at two times on the first day of the study and at two times (before and after saline infusion) on the second day | ||||
Mean weight or mass (and standard deviation), kg | ||||
Day 1 | Day 2 | |||
Measurement | Time 1 | Time 2 | Time 3 | Time 4 |
Weight | 73.0 (7.03) | 73.0 (7.02) | 72.9 (6.81) | 75.1* (6.99) |
Skinfold fat free mass | 62.7 (5.43) | 62.6 (5.43) | 62.3 (5.50) | 64.2* (5.65) |
DXA-derived total mass | 73.1 (7.04) | 73.0 (7.07) | 72.8 (6.84) | 75.2* (7.01) |
DXA-derived lean mass | 60.6 (5.59) | 60.9 (5.62) | 60.8 (5.77) | 63.7* (6.01) |
DXA-derived lean soft-tissue mass | 57.9 (5.34) | 58.2 (5.37) | 58.1 (5.53) | 61.0* (5.78) |
*Significantly different from times 1, 2 and 3, according to the Scheffé post-hoc test. |